Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

UCB launches Vimpat in the U.S. for add-on treatment of epilepsy in adults

May 28, 2009

Novel P2X3 receptor antagonists claimed by Merck & Co. as analgesics

May 28, 2009

Bristol-Myers Squibb submits CTA in Sweden to initiate phase I studies on drug for CNS diseases

May 27, 2009

FDA notifies Hemispherx of possible delay in FDA action on Ampligen

May 27, 2009

Abbott presents 5-HT6 receptor ligands for the treatment of cognitive dysfunctions

May 27, 2009

Sanofi-aventis presents novel histamine H3 receptor modulators for sleep disorders

May 27, 2009

Quetiapine improves PTSD measures in randomized study

May 27, 2009

Sanofi-aventis discovers novel vanilloid TRPV1 receptor antagonists for the treatment of pain

May 26, 2009

Novel T-type calcium channel blockers patented by Merck & Co. as antiepileptic agents

May 26, 2009

Angion Biomedica discovers novel PARP inhibitors for the treatment of stroke

May 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...